Rashed Asia N, Wong Ian C K, Wilton Lynda, Tomlin Stephen, Neubert Antje
Institute of Pharmaceutical Science, King's College London, King's Health Partners, 150 Stamford Street, London, SE1 9NH UK ; Pharmacy Department, Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, King's Health Partners, Westminster Bridge Road, London, SE1 7EH UK.
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China ; UCL School of Pharmacy, London, UK.
Drugs Real World Outcomes. 2015;2(4):397-410. doi: 10.1007/s40801-015-0049-y. Epub 2015 Nov 18.
To investigate and compare drug prescription patterns in children admitted to a paediatric general medical ward in five countries.
A prospective cohort study conducted on paediatric medical wards in the UK, Germany, Australia, Hong Kong (HK) and Malaysia. Data were collected over 3 months in each country except in Australia (1 month). All medications prescribed were classified according to the WHO Anatomical Therapeutic Chemical (ATC) classification. For each drug, frequency of prescriptions and patient exposures were calculated for ATC anatomical and therapeutic levels overall and by country.
One thousand two hundred and seventy-eight patients were included (Australia 146, Germany 376, UK 313, HK 143 and Malaysia 300); 89.2 % of patients (1140) received medications, median 3 (interquartile range 2-5) drugs per patient. 5367 drugs were prescribed. The most frequently prescribed therapeutic groups in all countries were: systemic antibacterials (1355; 25.2 %), analgesics/non-steroidal anti-inflammatory drugs (NSAIDs) (1173; 21.8 %) and drugs for obstructive airway diseases (472; 8.8 %). Overall, 65.1 % (742) of patients received at least one systemic antibacterial, 63.7 % (726) received one or more analgesic/NSAIDs, and 23.6 % (269) received 'drugs for obstructive airway diseases'. The number of patients exposed to these groups differed significantly between countries ( < 0.05). Paracetamol was the most frequently prescribed in all countries, but metamizole was only used in Germany. Morphine was mainly prescribed in the UK.
This study provides an overview of drug use patterns in five culturally and ethnically diverse countries. The most frequently used therapeutic groups were similar, but the proportion of patients treated differed between countries. Also within a therapeutic group the specific drug used varied between countries.
调查并比较五个国家儿科普通内科病房收治儿童的用药处方模式。
在英国、德国、澳大利亚、中国香港和马来西亚的儿科病房开展一项前瞻性队列研究。除澳大利亚为1个月外,每个国家的数据收集时长均为3个月。所有开具的药物均按照世界卫生组织解剖学治疗学化学(ATC)分类进行归类。针对每种药物,计算总体以及各个国家在ATC解剖学和治疗学层面的处方频率和患者暴露情况。
共纳入1278例患者(澳大利亚146例、德国376例、英国313例、中国香港143例以及马来西亚300例);89.2%的患者(1140例)接受了药物治疗,每位患者使用药物的中位数为3种(四分位间距为2 - 5种)。共开具了5367种药物。所有国家最常开具的治疗类别为:全身用抗菌药(1355种;25.2%)、镇痛药/非甾体抗炎药(NSAIDs)(1173种;21.8%)以及用于阻塞性气道疾病的药物(472种;8.8%)。总体而言,65.1%(742例)的患者接受了至少一种全身用抗菌药,63.7%(726例)接受了一种或多种镇痛药/NSAIDs,23.6%(269例)接受了“用于阻塞性气道疾病的药物”。不同国家接触这些类别的患者数量存在显著差异(<0.05)。对乙酰氨基酚在所有国家都是最常开具的药物,但安乃近仅在德国使用。吗啡主要在英国开具。
本研究概述了五个文化和种族多样的国家的用药模式。最常使用的治疗类别相似,但各国接受治疗的患者比例有所不同。而且在一个治疗类别内,各国使用的具体药物也存在差异。